DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes

Epigenomics

Volumn 7, Issue 3, 2015, Pages 451-460

  Rönn, Tina ^a   Ling, Charlotte ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

adipose tissue; BMI; CpG SNPs; epigenetics; exercise; HbA1c; insulin resistance; insulin secretion; pancreatic islets; skeletal muscle

Indexed keywords

AGING; ALTERNATIVE RNA SPLICING; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; ENHANCER REGION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE PHOSPHORYLATION; PANCREAS ISLET; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; DIABETES MELLITUS, TYPE 2; GENETIC EPIGENESIS; GENETICS; SECRETION (PROCESS);

INSULIN;

DIABETES MELLITUS, TYPE 2; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; INSULIN; INSULIN RESISTANCE;

EID: 84931301395     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.15.7     Document Type: Review

References (69)

1. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35(7), 595-601 (1992).
2. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36(1), 62-67 (1993).
3. Eriksson JG, Forsen T, Tuomilehto J, Jaddoe VW, Osmond C, Barker DJ. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia 45(3), 342-348 (2002).
4. Hales CN, Barker DJ, Clark PM et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303(6809), 1019-1022 (1991).
5. Lithell HO, Mckeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 312(7028), 406-410 (1996).
6. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to Type 2 diabetes and recent advances in the treatment and prevention. Int. J. Med. Sci. 11(11), 1185-1200 (2014).
7. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and Type 2 diabetes. Diabetes 58(12), 2718-2725 (2009).
8. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat. Rev. Genet. 11(3), 191-203 (2010).
9. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13(7), 484-492 (2012).
10. Cheng X, Blumenthal RM. Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry 49(14), 2999-3008 (2010).
11. Hashimoto H, Vertino PM, Cheng X. Molecular coupling of DNA methylation and histone methylation. Epigenomics 2(5), 657-669 (2010).
12. Muhonen P, Holthofer H. Epigenetic and microRNAmediated regulation in diabetes. Nephrol. Dial. Transplant. 24(4), 1088-1096 (2009).
13. Dayeh T, Volkov P, Salo S et al. Genome-wide DNA methylation analysis of human pancreatic islets from Type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 10(3), e1004160 (2014).
14. Volkmar M, Dedeurwaerder S, Cunha DA et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from Type 2 diabetic patients. EMBO J. 31(6), 1405-1426 (2012).
15. Hall E, Volkov P, Dayeh T et al. Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med. 12, 103 (2014).
16. Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of Type 2 diabetes. Nat. Genet. 38(3), 320-323 (2006).
17. Nogueira TC, Paula FM, Villate O et al. GLIS3, a susceptibility gene for Type 1 and Type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet. 9(5), e1003532 (2013).
18. Ling C, Del Guerra S, Lupi R et al. Epigenetic regulation of PPARGC1A in human Type 2 diabetic islets and effect on insulin secretion. Diabetologia 51(4), 615-622 (2008).
19. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1(6), 361-370 (2005).
20. Jonsson A, Isomaa B, Tuomi T et al. A variant in the KCNQ1 gene predicts future Type 2 diabetes and mediates impaired insulin secretion. Diabetes 58(10), 2409-2413 (2009).
21. Unoki H, Takahashi A, Kawaguchi T et al. SNPs in KCNQ1 are associated with susceptibility to Type 2 diabetes in East Asian and European populations. Nat. Genet. 40(9), 1098-1102 (2008).
22. Yasuda K, Miyake K, Horikawa Y et al. Variants in KCNQ1 are associated with susceptibility to Type 2 diabetes mellitus. Nat. Genet. 40(9), 1092-1097 (2008).
23. Travers ME, Mackay DJ, Dekker Nitert M et al. Insights into the molecular mechanism for Type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes 62(3), 987-992 (2013).
24. Kuroda A, Rauch TA, Todorov I et al. Insulin gene expression is regulated by DNA methylation. PLoS ONE 4(9), e6953 (2009).
25. Yang BT, Dayeh TA, Kirkpatrick CL et al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia 54(2), 360-367 (2011).
26. Yang BT, Dayeh TA, Volkov PA et al. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with Type 2 diabetes. Mol. Endocrinol. 26(7), 1203-1212 (2012).
27. Kaneto H, Miyatsuka T, Kawamori D et al. PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function. Endocr. J. 55(2), 235-252 (2008).
28. Drucker DJ. The biology of incretin hormones. Cell Metab. 3(3), 153-165 (2006).
29. Tornehave D, Kristensen P, Romer J, Knudsen LB, Heller RS. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J. Histochem. Cytochem. 56(9), 841-851 (2008).
30. Hall E, Dayeh T, Kirkpatrick CL, Wollheim CB, Dekker Nitert M, Ling C. DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets. BMC Med. Genet. 14, 76 (2013).
31. Kameswaran V, Bramswig NC, Mckenna LB et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human Type 2 diabetic islets. Cell Metab. 19(1), 135-145 (2014).
32. Benetatos L, Hatzimichael E, Londin E et al. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol. Life Sci. 70(5), 795-814 (2013).
33. Correa-Medina M, Bravo-Egana V, Rosero S et al. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr. Patterns 9(4), 193-199 (2009).
34. Wang Y, Liu J, Liu C, Naji A, Stoffers DA. MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic beta-cells. Diabetes 62(3), 887-895 (2013).
35. Canivell S, Ruano EG, Siso-Almirall A et al. Differential methylation of TCF7L2 promoter in peripheral blood DNA in newly diagnosed, drug-naive patients with Type 2 diabetes. PLoS ONE 9(6), e99310 (2014).
36. Del Rosario MC, Ossowski V, Knowler WC, Bogardus C, Baier LJ, Hanson RL. Potential epigenetic dysregulation of genes associated with MODY and Type 2 diabetes in humans exposed to a diabetic intrauterine environment: an analysis of genome-wide DNA methylation. Metabolism 63(5), 654-660 (2014).
37. Gu HF, Gu T, Hilding A et al. Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without Type 2 diabetes. Clin. Epigenetics 5(1), 20 (2013).
38. Gu T, Gu HF, Hilding A et al. Increased DNA methylation levels of the insulin-like growth factor binding protein 1 gene are associated with Type 2 diabetes in Swedish men. Clin Epigenetics 5(1), 21 (2013).
39. Toperoff G, Aran D, Kark JD et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum. Mol. Genet. 21(2), 371-383 (2012).
40. Isomaa B, Forsen B, Lahti K et al. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia 53(8), 1709-1713 (2010).
41. Nitert MD, Dayeh T, Volkov P et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with Type 2 diabetes. Diabetes 61(12), 3322-3332 (2012).
42. Barres R, Yan J, Egan B et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 15(3), 405-411 (2012).
43. Barres R, Osler ME, Yan J et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 10(3), 189-198 (2009).
44. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin. Endocrinol. (Oxf) 64(4), 355-365 (2006).
45. Ronn T, Volkov P, Davegardh C et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet. 9(6), e1003572 (2013).
46. Ronn T, Volkov P, Tornberg A et al. Extensive changes in the transcriptional profile of human adipose tissue including genes involved in oxidative phosphorylation after a 6-month exercise intervention. Acta Physiol. (Oxf) 211(1), 188-200 (2014).
47. Mccarthy MI. Genomics, Type 2 diabetes and obesity. N. Engl. J. Med. 363(24), 2339-2350 (2010).
48. Chen XW, Leto D, Chiang SH, Wang Q, Saltiel AR. Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev. Cell. 13(3), 391-404 (2007).
49. Singhal J, Nagaprashantha L, Vatsyayan R, Awasthi S, Singhal SS. RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome. PLoS ONE 6(9), e24688 (2011).
50. Nilsson E, Jansson PA, Perfilyev A et al. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes 63(9), 2962-2976 (2014).
51. Grundberg E, Meduri E, Sandling JK et al. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am. J. Hum. Genet. 93(5), 876-890 (2013).
52. Ribel-Madsen R, Fraga MF, Jacobsen S et al. Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for Type 2 diabetes. PLoS ONE 7(12), e51302 (2012).
53. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Diabetes 61(2), 542-546 (2012).
54. Simar D, Versteyhe S, Donkin I et al. DNA methylation is altered in B and NK lymphocytes in obese and Type 2 diabetic human. Metabolism 63(9), 1188-1197 (2014).
55. Gokulakrishnan K, Velmurugan K, Ganesan S, Mohan V. Circulating levels of insulin-like growth factor binding protein-1 in relation to insulin resistance, Type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118). Metabolism 61(1), 43-46 (2012).
56. Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Soderakra Cardiovascular Risk Factor Study. Diabetes Metab. 35(3), 198-205 (2009).
57. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 102(4), 401-414 (2008).
58. Gemma C, Sookoian S, Dieuzeide G et al. Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents. Mol. Genet. Metab. 100(1), 83-87 (2010).
59. Ling C, Poulsen P, Simonsson S et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J. Clin. Invest. 117(11), 3427-3435 (2007).
60. Ronn T, Poulsen P, Hansson O et al. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia 51(7), 1159-1168 (2008).
61. Mootha VK, Lindgren CM, Eriksson KF et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34(3), 267-273 (2003).
62. Jacobsen SC, Brons C, Bork-Jensen J et al. Effects of shortterm high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia 55(12), 3341-3349 (2012).
63. Dayeh TA, Olsson AH, Volkov P, Almgren P, Ronn T, Ling C. Identification of CpG-SNPs associated with Type diabetes and differential DNA methylation in human pancreatic islets. Diabetologia 56(5), 1036-1046 (2013).
64. Olsson AH, Volkov P, Bacos K et al. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets. PLoS Genet. 10(11), e1004735 (2014).
65. Bell CG, Finer S, Lindgren CM et al. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO Type 2 diabetes and obesity susceptibility locus. PLoS ONE 5(11), e14040 (2010).
66. Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826), 889-894 (2007).
67. Bhandare R, Schug J, Le Lay J et al. Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res. 20(4), 428-433 (2010).
68. Heintzman ND, Hon GC, Hawkins RD et al. Histone modifications at human enhancers reflect global cell-typespecific gene expression. Nature 459(7243), 108-112 (2009).
69. Tobi EW, Slagboom PE, Van Dongen J et al. Prenatal famine and genetic variation are independently and additively associated with DNA methylation at regulatory loci within IGF2/H19. PLoS ONE 7(5), e37933 (2012).